BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 294 filers reported holding BLUEBIRD BIO INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $314,000 | -15.6% | 3,580 | -11.7% | 0.03% | -25.0% |
| Q3 2019 | $372,000 | -41.6% | 4,055 | -19.0% | 0.04% | -41.2% |
| Q2 2019 | $637,000 | -18.3% | 5,005 | +1.0% | 0.07% | -20.9% |
| Q1 2019 | $780,000 | +54.8% | 4,955 | -2.5% | 0.09% | +28.4% |
| Q4 2018 | $504,000 | -49.2% | 5,080 | -25.3% | 0.07% | -42.7% |
| Q3 2018 | $993,000 | -6.9% | 6,800 | 0.0% | 0.12% | -14.0% |
| Q2 2018 | $1,067,000 | -4.6% | 6,800 | +3.8% | 0.14% | -3.5% |
| Q1 2018 | $1,118,000 | -4.0% | 6,550 | +0.2% | 0.14% | -7.8% |
| Q4 2017 | $1,164,000 | +29.6% | 6,535 | 0.0% | 0.15% | +30.8% |
| Q3 2017 | $898,000 | +13.4% | 6,535 | -13.3% | 0.12% | +10.4% |
| Q2 2017 | $792,000 | +15.6% | 7,535 | 0.0% | 0.11% | +12.8% |
| Q1 2017 | $685,000 | +106.9% | 7,535 | +40.3% | 0.09% | +100.0% |
| Q4 2016 | $331,000 | – | 5,370 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sessa Capital IM, L.P. | 1,834,965 | $35,066,000 | 1.72% |
| Birchview Capital, LP | 84,000 | $1,605,000 | 1.09% |
| ARMISTICE CAPITAL, LLC | 2,472,000 | $47,240,000 | 0.80% |
| EcoR1 Capital, LLC | 802,507 | $15,336,000 | 0.53% |
| Parametrica Management Ltd | 36,919 | $706,000 | 0.53% |
| Bain Capital Life Sciences Investors, LLC | 538,179 | $7,239,000 | 0.45% |
| APPLETON GROUP, LLC | 19,495 | $373,000 | 0.32% |
| MANGROVE PARTNERS IM, LLC | 175,587 | $3,355,000 | 0.30% |
| Quinn Opportunity Partners LLC | 230,100 | $4,397,000 | 0.28% |
| PDT Partners, LLC | 171,700 | $3,281,000 | 0.24% |